Clinical trial

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

NCT05586542

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

COMBINATION_PRODUCT · Unmapped registry intervention DERMASEAL Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Plasma Film Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Standard of Care Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-10-03

PhasePHASE1

Conditions

Foot Ulcer, Diabeticunresolved

Interventions

DERMASEALCOMBINATION_PRODUCT

Plasma FilmBIOLOGICAL

Standard of CareOTHER

Sponsors & collaborators

Vitruvian Medical Devices, Inc.lead sponsor

Mapped research locations

FresnoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05586542 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.